Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LncRNA regulator of macrophage immunity 1 (LROMI1; AC022816.1) is a long noncoding RNA identified as an important regulator of human macrophage immune functions. It is part of an NFκB-dependent lncRNA network that modulates macrophage responses by interacting with mRNA-processing proteins such as hnRNPs. The function of LROMI1 is defined by its ability to fine-tune immune activation in response to pathogens, coordinating transcriptional and post-transcriptional regulatory events essential for the innate immune response. LROMI1 does not encode a protein but acts as a scaffold or guide for molecular interactions that ultimately impact the phenotype and function of immune cells, particularly macrophages[2].
Not applicable; there are currently no drugs targeting LROMI1. Mechanistically, LROMI1 functions by binding mRNA processing factors and influencing transcriptional pathways (e.g., NFκB-dependent regulation)[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LncRNA regulator of macrophage immunity 1 (LROMI1).